April 5, 2019 — Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
April 05, 2019
April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...
April 03, 2019
April 2, 2019 — A Swedish review of out-of-hospital cardiac arrest data shows rates of bystander cardiopulmonary ...
April 02, 2019
March 29, 2019 — The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...
March 29, 2019
March 29, 2019 — A research team from Imperial College London believes a new software could speed up the diagnosis and ...
March 29, 2019
March 29, 2019 — Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and ...
March 29, 2019
Interview with Frederick Masoudi, M.D., FACC, FAHA, professor of cardiology at the University of Colorado Hospital, and ...
March 28, 2019
March 27, 2019 — Training interventional radiologists to perform endovascular thrombectomies results in positive ...
March 27, 2019![New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.](/sites/default/files/styles/content_feed_medium/public/Entresto_bottles.jpg?itok=sp56E5GI)
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril ...
March 27, 2019
March 25, 2019 — Patients who stopped taking aspirin one month after receiving a stent in the heart’s arteries but ...
March 25, 2019
March 25, 2019 — Phase 3 results from Study 2, also known as CLEAR WISDOM, of bempedoic acid were recently presented at ...
March 25, 2019
March 22, 2019 — Severely ill patients with advanced heart failure who received the HeartMate 3 left ventricular assist ...
March 22, 2019
March 22, 2019 — Among patients with severe symptomatic aortic stenosis at low surgical risk, transcatheter aortic valve ...
March 22, 2019
Khaldoun Tarakji, M.D., MPH, associate section head, section of electrophysiology and pacing in the Robert and Suzanne ...
March 21, 2019
Christine Albert, M.D., MPH, director of the Center for Arrhythmia Prevention at Brigham and Women’s Hospital, and ...
March 21, 2019